Tech Company Financing Transactions
Sofie BioSciences Funding Round
Sofie BioSciences closed a investment round on 6/5/2024. Backers included Trilantic North America.
Transaction Overview
Company Name
Announced On
6/5/2024
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate its growth initiatives, including expanding capacity and points of presence to improve patient access to its portfolio of radiopharmaceutical products.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6160 Bristol Pkwy. 200
Culver City, CA 90230
USA
Culver City, CA 90230
USA
Phone
Website
Email Address
Overview
By empowering a wide array of researchers with valuable, translational imaging tools, we are removing the dependency, cost, and complexity from PET.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Patrick Phelps
Chief Technical Officer
Melissa Moore
VP - Sales
Philipp Czernin
Browse more venture capital transactions:
Prev: 6/5/2024: Nucleus RadioPharma venture capital transaction
Next: 6/5/2024: Fispoke venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site come from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs